Financhill
Back

Corvus Pharmaceuticals Stock Predictions

Corvus Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, Corvus Pharmaceuticals has on average historically risen by 61.8% based on the past 8 years of stock performance.
  • Corvus Pharmaceuticals has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Corvus Pharmaceuticals Stock Undervalued?
    The current Corvus Pharmaceuticals [CRVS] share price is $8.19. The Score for CRVS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • CRVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Corvus Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, Corvus Pharmaceuticals has on average historically risen by 61.8% based on the past 8 years of stock performance.

Corvus Pharmaceuticals Stock Rating

Buy
56
Corvus Pharmaceuticals (CRVS) is a Buy

Is Corvus Pharmaceuticals overpriced?

  • Corvus Pharmaceuticals has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Corvus Pharmaceuticals Stock Price History

Is CRVS stock going to rise?

  • The current trend is moderately bearish and CRVS is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
corvuspharma.com

52-Week Data

52-Week High:
10.00
52-Week Low:
1.30

Prediction Charts

Market Cap:
512.3M
Price in USD:
8.19
Volume:
2.35M
Beta:
1.07

Technical Analysis

SMA50:
6.77
SMA100:
4.86
SMA200:
3.41
52-Wk Change:
442.38%

Stock Predictions

  • Is Corvus Pharmaceuticals stock public?
    Yes, Corvus Pharmaceuticals is a publicly traded company.
  • What is the Corvus Pharmaceuticals stock quote today?
    The Corvus Pharmaceuticals stock price is 8.19 USD today.
  • How to buy Corvus Pharmaceuticals stock online?
    You can buy Corvus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-29 8.61 8.88 8.96 8.45
Oct-30 9.00 8.80 9.19 8.55
Oct-31 8.66 8.84 9.03 8.51
Nov-1 8.95 9.10 9.28 8.82
Nov-4 8.99 9.02 9.37 7.91
Nov-5 8.93 9.23 9.44 8.87
Nov-6 9.66 8.78 9.70 8.50
Nov-7 8.67 8.80 9.10 8.43
Nov-8 8.71 9.45 9.61 8.62
Nov-11 9.63 9.56 9.90 9.28
Nov-12 9.40 8.69 9.70 8.67
Nov-13 9.96 8.89 10.00 8.79
Nov-14 8.94 8.52 9.00 7.89
Nov-15 8.40 8.19 8.51 7.78

Corvus Pharmaceuticals Earnings

Corvus Pharmaceuticals Earnings Report: Per Share Corvus Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

Corvus Pharmaceuticals Forecast Revenue Growth

Corvus Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Corvus Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and an increase next year of $0.42 per share.

* Corvus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.